National AIDS programmes

A guide to indicators for monitoring and evaluating national antiretroviral programmes

21 February 2005

ISBN 92 4 159291 5

Between five and six million people infected with HIV in the developing world need antiretroviral therapy (ART) in order to survive but at the end of 2004, only 700 000 had access to it (range 630 000-780 000; in developing and transitional countries). This represents a global health emergency, in response to which WHO and partner organizations have committed themselves to work towards providing treatment to all who need it. Initially, it is intended to reach three million people on antiretroviral drugs (ARVs) by the end of 2005. This is called the “3 by 5” global target.

High priority is given to the monitoring and evaluation (M&E) of this rapid scale-up of ART. It will be crucial to know how countries are meeting the agreed goals and objectives and how local levels (districts, regions or provinces, and health facilities) are monitoring progress and identifying any problems that they encounter.

This working document represents the best possible effort to describe a coherent approach to national M&E of the scaling up of access to ART, with the aim of providing universal access. It is best viewed as a step in a process that will include the gathering of additional experience, additional review, the validation of indicators presented, and, subsequently, refinement. New lessons learnt will be used to update and correct the document, as experience in M&E of this area increases.